Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moerman

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|August 2, 2015
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapiesJeroen Depreeuw, Els Hermans, Stefanie Schrauwen, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
International Journal of Cancer|October 25, 2017
Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathwaysTine Cuppens, Matthieu Moisse, Jeroen Depreeuw, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatmentEvelyn Despierre, Betül T Yesilyurt, Sandrina Lambrechts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, et al.
International Journal of Cancer|August 21, 2013
Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcomaBarbara Dewaele, Joanna Przybyl, Anna Quattrone, et al.
American Journal of Medical Genetics. Part A|April 11, 2003
Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndromeJohan L K Van Hove, Ron A Wevers, Johan Van Cleemput, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvementPatrick Neven, Olivier Brouckaert, Vanya Van Belle, et al.
Gynecologic Oncology|December 11, 2012
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinomaDiego A Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, et al.
JAMA Oncology|September 11, 2015
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal TestingFrédéric Amant, Magali Verheecke, Iwona Wlodarska, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|August 2, 2015
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapiesJeroen Depreeuw, Els Hermans, Stefanie Schrauwen, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
International Journal of Cancer|October 25, 2017
Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathwaysTine Cuppens, Matthieu Moisse, Jeroen Depreeuw, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2014
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatmentEvelyn Despierre, Betül T Yesilyurt, Sandrina Lambrechts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, et al.
International Journal of Cancer|August 21, 2013
Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcomaBarbara Dewaele, Joanna Przybyl, Anna Quattrone, et al.
American Journal of Medical Genetics. Part A|April 11, 2003
Late-Onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndromeJohan L K Van Hove, Ron A Wevers, Johan Van Cleemput, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvementPatrick Neven, Olivier Brouckaert, Vanya Van Belle, et al.
Gynecologic Oncology|December 11, 2012
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinomaDiego A Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, et al.
JAMA Oncology|September 11, 2015
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal TestingFrédéric Amant, Magali Verheecke, Iwona Wlodarska, et al.
Pageof 10